Nellix Device Failure Mechanisms Analysis on Explanted Grafts.

IF 1.7 2区 医学 Q3 PERIPHERAL VASCULAR DISEASE Journal of Endovascular Therapy Pub Date : 2024-08-27 DOI:10.1177/15266028241274736
Léna Christ, Salomé Kuntz, Damir Vakhitov, Laurent Raibaut, Nicole Neumann, Frédéric Heim, Nabil Chakfé, Anne Lejay
{"title":"Nellix Device Failure Mechanisms Analysis on Explanted Grafts.","authors":"Léna Christ, Salomé Kuntz, Damir Vakhitov, Laurent Raibaut, Nicole Neumann, Frédéric Heim, Nabil Chakfé, Anne Lejay","doi":"10.1177/15266028241274736","DOIUrl":null,"url":null,"abstract":"<p><strong>Objective: </strong>To understand possible reasons for poor durability of the Nellix (Endologix Inc., Irvine, USA) endovascular aneurysm sealing (EVAS) device.</p><p><strong>Materials and methods: </strong>21 Nellix endoprostheses explanted for endoleaks and migration underwent visual examinations of stent structures and instrumental examinations of the polymer endobags on 4 devices. We harvested 2.0-gram polymer slices out of each of them and tested the samples in an in vitro implantation replication that included wet and dry exposures. During the wet phase, we placed samples in a beaker with saline, mimicking the filling of the endobags during implantation. An exposure to a 37°C environment with 60% humidity during the dry phase replicated the postimplantation conditions inside the aneurysmal sac.</p><p><strong>Results: </strong>Iatrogenic defects affected 16 (76%) metal stents and 20 (95%) endobags. The polymer was disintegrated owing to degradation in 15 (71%) cases. The polymer could lose more than 70% of its initial weight when partially dehydrated and regain 80% when placed in saline. We observed volume decrease and polymer fragmentation during these study phases.</p><p><strong>Conclusions: </strong>The polymer can lose weight and volume while it dehydrates. This structural degradation of the polymer could lead to the development of endoleaks and/or migration of the device.</p><p><strong>Clinical impact: </strong>Based on the results of previous investigations, due to possible endovascular device degradation, patients with endografts should be offered life-long surveillance, and the Nellix device is no exception. Herein we suggest polymer degradation as one of the possible reasons for the device failure. Although Nellix has been withdrawn from the market, there are numerous patients with this type of endograft. Due to its unpredictable performance in the medium and long term, these patients should be recommended enhanced life-long surveillance every 6 months. Any suspicious conditions during the follow-up must be taken seriously and explantation should be considered.</p>","PeriodicalId":50210,"journal":{"name":"Journal of Endovascular Therapy","volume":null,"pages":null},"PeriodicalIF":1.7000,"publicationDate":"2024-08-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Endovascular Therapy","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1177/15266028241274736","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"PERIPHERAL VASCULAR DISEASE","Score":null,"Total":0}
引用次数: 0

Abstract

Objective: To understand possible reasons for poor durability of the Nellix (Endologix Inc., Irvine, USA) endovascular aneurysm sealing (EVAS) device.

Materials and methods: 21 Nellix endoprostheses explanted for endoleaks and migration underwent visual examinations of stent structures and instrumental examinations of the polymer endobags on 4 devices. We harvested 2.0-gram polymer slices out of each of them and tested the samples in an in vitro implantation replication that included wet and dry exposures. During the wet phase, we placed samples in a beaker with saline, mimicking the filling of the endobags during implantation. An exposure to a 37°C environment with 60% humidity during the dry phase replicated the postimplantation conditions inside the aneurysmal sac.

Results: Iatrogenic defects affected 16 (76%) metal stents and 20 (95%) endobags. The polymer was disintegrated owing to degradation in 15 (71%) cases. The polymer could lose more than 70% of its initial weight when partially dehydrated and regain 80% when placed in saline. We observed volume decrease and polymer fragmentation during these study phases.

Conclusions: The polymer can lose weight and volume while it dehydrates. This structural degradation of the polymer could lead to the development of endoleaks and/or migration of the device.

Clinical impact: Based on the results of previous investigations, due to possible endovascular device degradation, patients with endografts should be offered life-long surveillance, and the Nellix device is no exception. Herein we suggest polymer degradation as one of the possible reasons for the device failure. Although Nellix has been withdrawn from the market, there are numerous patients with this type of endograft. Due to its unpredictable performance in the medium and long term, these patients should be recommended enhanced life-long surveillance every 6 months. Any suspicious conditions during the follow-up must be taken seriously and explantation should be considered.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
Nellix 装置故障机理分析(已取出的移植物)。
目的:了解 Nellix(Endologix Inc:材料和方法:对因内漏和移位而取出的 21 个 Nellix 内支架进行了支架结构的目视检查,并对 4 个设备上的聚合物内袋进行了仪器检查。我们从每个器械中提取了 2.0 克的聚合物切片,并在体外植入复制中对样本进行了测试,其中包括湿暴露和干暴露。在湿法阶段,我们将样品放入装有生理盐水的烧杯中,模拟内袋在植入过程中的填充情况。在干燥阶段,将样本置于37°C、湿度为60%的环境中,复制动脉瘤囊内植入后的情况:结果:16 个(76%)金属支架和 20 个(95%)内袋出现先天性缺陷。聚合物因降解而解体的有 15 例(71%)。聚合物在部分脱水的情况下会损失超过 70% 的初始重量,而在生理盐水中则会恢复 80%。在这些研究阶段,我们观察到了体积的减少和聚合物的破碎:结论:聚合物在脱水过程中会失去重量和体积。结论:聚合物在脱水过程中会失去重量和体积,聚合物的这种结构降解可能会导致内漏的形成和/或装置的移位:临床影响:根据之前的研究结果,由于血管内移植物可能会发生降解,因此应为内移植物患者提供终身监护,Nellix 装置也不例外。在此,我们认为聚合物降解是导致装置失效的可能原因之一。虽然 Nellix 已退出市场,但仍有许多患者使用这种内植物。由于其中长期性能难以预测,建议对这些患者每 6 个月进行一次终身监测。必须认真对待随访期间出现的任何可疑情况,并考虑进行移植手术。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
CiteScore
5.30
自引率
15.40%
发文量
203
审稿时长
6-12 weeks
期刊介绍: The Journal of Endovascular Therapy (formerly the Journal of Endovascular Surgery) was established in 1994 as a forum for all physicians, scientists, and allied healthcare professionals who are engaged or interested in peripheral endovascular techniques and technology. An official publication of the International Society of Endovascular Specialists (ISEVS), the Journal of Endovascular Therapy publishes peer-reviewed articles of interest to clinicians and researchers in the field of peripheral endovascular interventions.
期刊最新文献
Vascular Closure Devices For Axillary Artery Access: A Systematic Review and Meta-Analysis. A Statistical Shape Model of Infrarenal Aortic Necks in Patients With and Without Late Type Ia Endoleak After Endovascular Aneurysm Repair. Monocentric Evaluation of Physician-Modified Fenestrations or Parallel Endografts for Complex Aortic Diseases. Ethanol Embolization of Chest Wall Arteriovenous Malformations: Four-Year Findings. Deep Learning Prediction for Distal Aortic Remodeling After Thoracic Endovascular Aortic Repair in Stanford Type B Aortic Dissection.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1